top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Veterinary Endoscopes Market Trends Will Generate New Growth Opportunities in Upcoming Year

0 votes
6 views

Pets are the proven true companies to humans. Since years, pets are considered as family and this association with them has grown than ever before. People now are willing to spend huge sum of money in up keeping of their pets. Thus, with the growing pet population across the globe has augmented growth in various veterinary services. Moreover, one of the major market in which the demand is rising is veterinary endoscopes market. Pets usually face gastrointestinal issues leading to gastrointestinal diseases in some cases. Due to this rise, the demand in the veterinary endoscopes market has increased significantly globally. Endoscopes help in examining esophagus, abdomen, bladder, and other internal organs.

Pets being such as important part, the need to analysis growth prospects in this market are important. In the report published by Transparency Market Research on the global veterinary endoscopes market, gives crucial information related to the growth of this market. Revenue growth rate for the global veterinary endoscopes is estimated to be 6.7% over the projected tenure from 2017 to 2025. If the market rises at this rate revenue generation will increase to US$ 728.1 billion by the end of 2025. This figure is substantially higher than US$405.1 million earned in 2016, thus creating an incremental opportunity of approximately US$ 323 million over the forecast tenure. With high revenue generation opportunity, players operating in this market are likely to generate high profits in the coming years.

Prominent players analyzed in the global veterinary endoscopes market report by TMR include Olympus Corporation, Harvard Bioscience Infiniti Medical, KARL STORZ SE & Co. KG, Fujifilm Holdings Corporation,  and Richard Wolf GmbH, STERIS plc. Leading players are using new and advanced business development strategies to get larger share in the market. New product launches, higher investment in research and development, they are also engaged in establishing partnership through collaboration and acquisition.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30518

Importance of Internal Examination has Boosted Gastrointestinal Endoscopy Procedures

Application of veterinary endoscopes is widely seen in diagnostics segment. Increasing gastrointestinal issues among pets and difficulty faced while finding the actual cause of the disease without the internal examination has fueled demand for veterinary endoscopes. In terms of procedure, gastrointestinal segment is leading the market. Stats as per the Journal of Veterinary Medicine and Animal Health state that the occurrences of gastrointestinal parasitic infection in tethered animals are extremely high.  Moreover, the gastrointestinal parasitic infection has affected large number of cattle across the globe. Thus, with the increasing share of the gastrointestinal endoscopy procedure over bronchoscopy, laparoscopy, cystoscopy, and otoscopy segments is likely to drive growth in the global veterinary endoscopes market.    

Growing Preference for Companion Pets Made North America a Key Region for Veterinary Endoscopes Market

With respect to regional growth, importance and use of veterinary endoscopes is high in North America due to rising companion animals in the region. Moreover, developed and advanced veterinary healthcare infrastructure and increasing pet healthcare insurance has made the region a leading market for the growth of veterinary endoscopes. Stats based on American Society for the Prevention of Cruelty to Animals (ASPCA) reveal that every year nearly 6.5 million companion animals arrive at the US animal shelters nationwide, which increases the use of veterinary endoscopes to completely analyze these pets. This factor has also augmented the growth in the global veterinary endoscopes market.

On the other hand, Asia Pacific is also considered a key region for the growth of the global veterinary endoscopes market. Growing preference for companion pets is the major reason behind the growth of veterinary endoscopes in this region.

More Trending Reports by Transparency Market Research –

Back Table and Cart Covers Market: https://www.prnewswire.com/news-releases/back-table-and-cart-covers-market-to-register-steady-3-2-cagr-during-2019-2027-transparency-market-research-300999428.html

Viral Vector Plasmid DNA Manufacturing Market: https://www.prnewswire.com/news-releases/global-viral-vector--plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html

posted 6 days ago by Bella Watson

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Longevity & Anti-senescence Therapy Market: Introduction

Aging is characterized by a progression in losing of physiological integrity and function over time. Aging epigenetics refers to changes in gene expression that naturally occur during an organismal lifespan without altering the DNA sequence. Chromatin epigenetics is regulated by several enzymes, which collectively give rise to modifications in DNA methylation and histone methylation/acetylation processes. During aging, chromatin appears to be in a more active state, with an overall decrease in DNA methylation, thus leading to more relaxed global gene expression.

Report Overview @ https://www.transparencymarketresearch.com/longevity-anti-senescence-therapy-market.html

Senescent cells are linked with many age-related diseases such as neurodegenerative diseases (Alzheimer’s and Parkinson’s disease; AD and PD, respectively), cataract, glaucoma, cardiovascular diseases (CVD, atherosclerosis, and hypertension), chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), diabetes type II, sarcopenia, osteoarthritis, osteoporosis, and certain types of tumors. The development of science and medicine has contributed to the increase in human lifespan. However, with increase in life expectancy, an increase in incidence of age-related diseases has been observed.

Therefore, it is crucial to find an approach to prevent or delay ageing and the onset of age-related diseases. The only non-genetic approach that can extend longevity is dietary/calorie restriction (DR/CR). This intervention involves a 20% to 40% reduction in calorie intake without causing malnutrition and has been shown to be effective in several species including yeast, fruit flies, nematodes, rats, dogs, and even primates.

Request PDF Sample of Longevity & Anti-senescence Therapy Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=75543

Key Drivers of Global Longevity & Anti-senescence Therapy Market

Increase in Geriatric Population Worldwide

The world’s geriatric population continues to grow at an unprecedented rate. Today, 8.5% of people worldwide (617 million) are aged 65 and over. According to a new report – ‘An Aging World: 2015’, the percentage is projected to jump to nearly 17% of the world’s population by 2050 (1.6 billion).

According to the National Institutes of Health, America’s 65-and-over population is projected to nearly double over the next three decades, from 48 million to 88 million by 2050. The global population of the people aged 80 and older is expected to more than triple between 2015 and 2050, growing from 126.5 million to 446.6 million. The population aged 80 and above in some countries in Asia and Latin America is predicted to quadruple by 2050.

Rise in Awareness of Antiaging Products among Generation Y and Later Generations

Anti-wrinkle products are gaining traction as they have formulation well suited to slower the aging process. Major causes of wrinkles include the lack of essential nutrients in the body, exposure to UV light and pollution for higher duration, smoking, dehydration, and drugs, along with other genetic factors. Greater aging anxiety and higher importance of appearance were related to greater likelihood of purchasing anti-aging products.

Pre Book “Longevity & Anti-senescence Therapy Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=75543&ltype=S

North America to Hold Major Share of Global Longevity & Anti-senescence Therapy Market

  • North America is expected to hold major share of the global longevity & anti-senescence therapy market during the forecast period. The market in North America is estimated to expand at a rapid pace in the near future, primarily, due to structured reimbursement policies, increase in prevalence of obesity & cardiovascular diseases, developed health care infrastructure, and continuous research activities in developing advanced technologies in North America.
  • The longevity & anti-senescence therapy market in Asia Pacific is projected to expand at a rapid pace during the forecast period. This can be attributed to growing trend of preventive health care measures in North America.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Longevity & Anti-senescence Therapy Market Report

Key Players Operating in Global Market

The global longevity & anti-senescence therapy market is highly concentrated, due to strong presence of a few key players. Several manufacturers hold major share in the market in their respective regions. Leading players operating in the global longevity & anti-senescence therapy market are:

  • Acorda Therapeutics
  • Calico Life Sciences
  • Human Longevity Inc.
  • Insilico Medicine
  • Oisin Biotechnology
  • Proteostasis Therapeutics Inc.
  • Recursion Pharmaceuticals
  • Restorbio
  • Senex Biotechnology
  • Senolytic Therapeutics
  • Sierra Sciences LLC

More Trending Reports by Transparency Market Research –

Hearing Aids Market: prnewswire.com/news-releases/hearing-aids-market-increasing-prevalence-of-hearing-loss-worldwide-augments-product-demand-says-tmr-300857268.html

Diabetes Drugs Market: prnewswire.com/news-releases/diabetes-drugs-market-value-to-reach-us584-billion-by-the-end-of-2025-transparency-market-research-663610203.html

0 votes

The global ostomy drainage bags market is a highly competitive market with a large number of local and international players operating across the globe, states a new market research study by Transparency Market Research. The key players in the market are focusing on the research and development activities in order to enhance their product portfolio and maintain their leading position throughout the forecast period. In addition to this, the rising number of strategic collaborations and mergers and acquisitions is projected to offer potential growth opportunities for the market players in the next few years. Some of the leading players operating in the ostomy drainage bags market across the globe are Pelcin Healthcare Ltd., B. Braun Melsungen AG, Flexicare Medical Limited, Salts Healthcare Ltd., ALCARE Co. Ltd., and Welland Medical Ltd. As per the study, the competition among the players is estimated to get stiff over the years.

According to the market research study by Transparency Market Research, the global market for ostomy drainage bags is expected to reach a value of US$2.75 bn by the end of 2022. The market is predicted to register a healthy 4.70% CAGR between 2014 and 2022.

Request a Sample of Ostomy Drainage Bags Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=325

Europe to Register Strong Growth Rate in Coming Few Years

The global ostomy drainage bags market has been classified on the basis of geography into Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Among these, Europe is expected to hold for a large share of the market and maintain its leading position throughout the forecast period. The strong growth of this region can be attributed to the rising disposable income of consumers and the willingness of patients to spend on healthcare requirements. Moreover, the favorable reimbursement policies by governments is expected to support the growth of the Europe market in the near future. On the other hand, Asia Pacific is expected to witness a strong growth rate in the next few years. The rising prevalence of colorectal cancer, especially in developing economies is estimated to encourage the growth of this segment throughout the forecast period.

In terms of product type, the global ostomy drainage bags market has been classified into urostomy bags, colostomy bags, and ileostomy bags. Among these, the colostomy bags segment is predicted to lead with a large share of the global market in the next few years. The high demand for colostomy bags, thanks to the rising awareness among consumers regarding colostomy and the increasing geriatric population are some of the key factors that are projected to accelerate the growth of this segment in the next few years. In addition to this, the rising contribution from the developing economies in Asia Pacific and Latin America is another factor that is likely to boost the growth in the coming years.

Increasing Patient Awareness to Encourage Market Growth in Coming Years

The rising cases of several diseases, including urinary tract cancer, colorectal cancer, and bladder cancer is one of the key factors that is estimated to enhance the growth of the global ostomy drainage bags market throughout the forecast period. The rising number of health disorders owing to the unhealthy lifestyle and the rising geriatric population are projected to accelerate the growth of the market in the near future. On the flip side, the medical risks by using ostomy bags is a major factor that is likely to restrict the growth of the market in the near future. Nonetheless, the favorable government reimbursement policies and the rising awareness among people are likely to offer potential growth opportunities for the market players in the near future.

This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Ostomy Drainage Bags Market (Types – Colostomy Bags, Ileostomy Bags, and Urostomy Bags; Use – Single-use and Multi-use Ostomy Drainage Bags) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”

Key Takeaways:

  • The favorable government policies and the development of the healthcare sector to encourage the growth of the global ostomy drainage bags market in the coming years.
  • Technological advancements and research activities to accelerate the growth of the ostomy drainage bags market across Europe in the near future.

More Trending Reports by Transparency Market Research –

Medical Image Analysis Software Market: prnewswire.com/news-releases/medical-image-analysis-software-market-to-obtain-a-valuation-of-us-4-6-bn-by-2024-says-tmr-836666587.html

Pharmerging Market: prnewswire.com/news-releases/pharmerging-market-to-hit-us1-40-billion-by-2024—says-tmr-300800262.html

0 votes

The demand within the global compression therapy market is growing in lieu of advancements in healthcare diagnosis, testing, and analysis. The need to treat paralyzing diseases related to the lower limbs has created new opportunities for growth within the global market. Furthermore, compression therapy enhances the ability of the limbs to move freely by improving blood flow through the vessels. Vein support is amongst the key benefits served by compression therapy, and this is an important dynamic of market growth. Poor or improper blood circulation is responsible for several diseases in the human body. Therefore, use of compression therapy to facilitate proper blood flood, and subsequently reduce swelling in the lower limbs, has aided market growth.

Transparency Market Research (TMR), in its report, finds that the global compression therapy market would expand at a respectable CAGR of 5.44% over the period between 2017 and 2024. Furthermore, the total value of the global compression therapy market is expected to reach US$4.25 billion by 2024-end, rising up from a volume of US$2.93 billion as of 2017.

Request PDF Sample of Compression Therapy Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1537

Research and Development Involved in Manufacturing Compression Stockings

Compression stockings are manufactured with immense precision and care. The favourable action of these stockings on regulating blood flow has created new opportunities within the global market. The unprecedented need for improving muscular health has also emerged as a key driver of market demand. Therefore, the total revenues within the global compression therapy market are expected to increase by a dramatic margin in the years to follow. The healthcare industry has become increasingly inclined towards improved lines of treatment. This factor, coupled with the availability of elastic garment apparels used for compression stockings, has pushed market growth.

Use of Compression Therapy in Treatment of Limb Injuries

The rising incidence of chronic venous disease has played an integral role in driving sales across the global compression therapy market. Leg injuries, in severe cases, can only be treated through surgical procedures. Obesity is also a sound contributor to the incidence of venous diseases. For this reason, the total volume of revenues within the global compression therapy market is slated to reach new heights. Children are also prone to suffering from venous diseases as a result of blood clots. People with minimal movement through the day are prone to the incidence of suffering diseases in the lower limbs.

Buy Now “Compression Therapy Market ” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1537&ltype=S

Availability of compression stockings of various sizes and grades has garnered the attention of the consumers. Farrow wraps are amongst the most popular types of compression therapy stockings used in the medical industry. Furthermore, clinicians also recommend the use of compression therapy in patients suffering from prolonged problems in limb movement. The quest of the healthcare industry to foster improvements in treatment of rare disease shall impel market growth.

0 votes

Transparency Market Research (TMR) has published a new report titled, “Parenteral Nutrition Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global parenteral nutrition market was valued at US$ 5,299.5 Mn in 2017. It is projected to expand at a CAGR of 4.7% from 2018 to 2026. High prevalence of chronic disorders, rise in cases of malnutrition, and new product approvals are anticipated to drive the global market in the next few years.

North America is expected to dominate the global parenteral nutrition market during the forecast period, followed by Europe. High prevalence of malnutrition in hospitalized patients, increase in the geriatric population, and approvals of novel parenteral nutrition combination in the U.S. and Europe are likely to drive the parenteral nutrition market in these regions during the forecast period. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period.

High prevalence and increase in incidence rate of chronic diseases to drive market

High prevalence and rise in incidence rate of chronic diseases across the globe is a key factor driving the global parenteral nutrition market. The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also fuelled the consumption of parenteral nutrition in recent years. For instance, according to International Agency for Research on Cancer (IARC), around 18.1 million new cases and 9.6 million deaths are estimated to have occurred in 2018.

Request PDF Sample of Parenteral Nutrition Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611

Moreover, the National Kidney Foundation stated that around 10% of the world’s population is affected by chronic kidney disease each year. The Centers for Disease Control and Prevention also noted that more than 30 million people in the U.S. have chronic kidney disease in the year 2017. Thus, the high prevalence and substantial rise in incidence rate of chronic diseases across the globe is a key factor driving the global parenteral nutrition market.

Parenteral lipid emulsions to propel the parenteral nutrition market

The report offers a detailed segmentation of the global parenteral nutrition market based on different types of nutrition administered to the patients. Based on type of nutrition, the global market has been segmented into carbohydrates, parenteral lipid emulsions, single dose amino acid solutions, trace elements, electrolytes, & minerals, and vitamins. Infusion of lipid emulsions delivers high energy supply, facilitates the prevention of high glucose infusion rates, and is necessary for the supply of essential fatty acids. Expansion of the parenteral lipid emulsions segment is due to its potential benefits to use as a drug delivery vehicle. For instance, administration of lipid emulsions act as essential drug carriers, which results in reduced pain, irritation, and prevention of thrombophlebitis.

Moreover, lipid emulsions containing a mixture of medium and long chain triglycerides (MCT/LCT) have proven to be highly effective in critically-ill patients. This mixture of lipid emulsion does not hamper the functioning of the liver and causes minimal interference with pulmonary hemodynamics. According to the Society of Critical Care Medicine, 5.7 million patients are admitted to the intensive care unit in the U.S. every year. Most of these include critically-ill patients who need high level of acute care. Thus, rising number of critically-ill patients is likely to boost the lipid emulsions segment during the forecast period.

Enquiry for Discount on “Parenteral Nutrition Market” Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3611

Asia Pacific offers high incremental opportunity

The parenteral nutrition market in Asia Pacific is projected to expand at a notable CAGR of 7.9% during the forecast period. High prevalence of chronic kidney disorders in highly populated countries, such as China and India, rapid improvement in health care infrastructure, increase in access to health care facilities, and rise in per capita health care expenditure in the region are likely to fuel the market in Asia Pacific during the forecast period. Large base of pharmaceutical companies in countries such as India, Japan, and China also drives the market in the region. Emerging economies and expansion of pharmaceutical markets in countries, such as China, India, Indonesia, Singapore, Taiwan, and Thailand are expected to propel the market in Asia Pacific. Rising cases of preterm birth, which leads to malnutrition, is a key reason fuelling the consumption of parenteral nutrition in Asia Pacific.

Key trend of new product development and commercialization to strengthen parenteral nutrition product portfolio

The global parenteral nutrition market is highly consolidated, with a few global players accounting for a major share in respective regions. Leading players in parenteral nutrition are trying to seek approvals for their new parenteral nutrition formulations from concerned authorities, such as the U.S. FDA, in order to launch new products in the market. This effort is focused at both grabbing new market shares and providing for the deficit of parental nutrition in developing regions. The leading players shaping the vendor landscape of the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius Kabi AG, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, and Pfizer, Inc.

0 votes

Transparency Market Research (TMR) has published a new report titled, “Parenteral Nutrition Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global parenteral nutrition market was valued at US$ 5,299.5 Mn in 2017. It is projected to expand at a CAGR of 4.7% from 2018 to 2026. High prevalence of chronic disorders, rise in cases of malnutrition, and new product approvals are anticipated to drive the global market in the next few years.

North America is expected to dominate the global parenteral nutrition market during the forecast period, followed by Europe. High prevalence of malnutrition in hospitalized patients, increase in the geriatric population, and approvals of novel parenteral nutrition combination in the U.S. and Europe are likely to drive the parenteral nutrition market in these regions during the forecast period. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period.

High prevalence and increase in incidence rate of chronic diseases to drive market

High prevalence and rise in incidence rate of chronic diseases across the globe is a key factor driving the global parenteral nutrition market. The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also fuelled the consumption of parenteral nutrition in recent years. For instance, according to International Agency for Research on Cancer (IARC), around 18.1 million new cases and 9.6 million deaths are estimated to have occurred in 2018.

Request PDF Sample of Parenteral Nutrition Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611

Moreover, the National Kidney Foundation stated that around 10% of the world’s population is affected by chronic kidney disease each year. The Centers for Disease Control and Prevention also noted that more than 30 million people in the U.S. have chronic kidney disease in the year 2017. Thus, the high prevalence and substantial rise in incidence rate of chronic diseases across the globe is a key factor driving the global parenteral nutrition market.

Parenteral lipid emulsions to propel the parenteral nutrition market

The report offers a detailed segmentation of the global parenteral nutrition market based on different types of nutrition administered to the patients. Based on type of nutrition, the global market has been segmented into carbohydrates, parenteral lipid emulsions, single dose amino acid solutions, trace elements, electrolytes, & minerals, and vitamins. Infusion of lipid emulsions delivers high energy supply, facilitates the prevention of high glucose infusion rates, and is necessary for the supply of essential fatty acids. Expansion of the parenteral lipid emulsions segment is due to its potential benefits to use as a drug delivery vehicle. For instance, administration of lipid emulsions act as essential drug carriers, which results in reduced pain, irritation, and prevention of thrombophlebitis.

Moreover, lipid emulsions containing a mixture of medium and long chain triglycerides (MCT/LCT) have proven to be highly effective in critically-ill patients. This mixture of lipid emulsion does not hamper the functioning of the liver and causes minimal interference with pulmonary hemodynamics. According to the Society of Critical Care Medicine, 5.7 million patients are admitted to the intensive care unit in the U.S. every year. Most of these include critically-ill patients who need high level of acute care. Thus, rising number of critically-ill patients is likely to boost the lipid emulsions segment during the forecast period.

Enquiry for Discount on “Parenteral Nutrition Market” Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3611

Asia Pacific offers high incremental opportunity

The parenteral nutrition market in Asia Pacific is projected to expand at a notable CAGR of 7.9% during the forecast period. High prevalence of chronic kidney disorders in highly populated countries, such as China and India, rapid improvement in health care infrastructure, increase in access to health care facilities, and rise in per capita health care expenditure in the region are likely to fuel the market in Asia Pacific during the forecast period. Large base of pharmaceutical companies in countries such as India, Japan, and China also drives the market in the region. Emerging economies and expansion of pharmaceutical markets in countries, such as China, India, Indonesia, Singapore, Taiwan, and Thailand are expected to propel the market in Asia Pacific. Rising cases of preterm birth, which leads to malnutrition, is a key reason fuelling the consumption of parenteral nutrition in Asia Pacific.

Key trend of new product development and commercialization to strengthen parenteral nutrition product portfolio

The global parenteral nutrition market is highly consolidated, with a few global players accounting for a major share in respective regions. Leading players in parenteral nutrition are trying to seek approvals for their new parenteral nutrition formulations from concerned authorities, such as the U.S. FDA, in order to launch new products in the market. This effort is focused at both grabbing new market shares and providing for the deficit of parental nutrition in developing regions. The leading players shaping the vendor landscape of the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius Kabi AG, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, and Pfizer, Inc.

...